ARS Pharmaceuticals (SPRY) Q1 2025 Earnings

Mar 20Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.24
0
0.24
0.48

Details

Expected EPS
-0.2375
Actual EPS
0.48
Surprise EPS
0.72
Surprise Percent
+302.11%

Description

⁨ARS Pharmaceuticals⁩ (⁦SPRY⁩) has reported earnings of ⁦0.48⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts